首药控股-U
(688197)
| 流通市值：20.77亿 | | | 总市值：48.26亿 |
| 流通股本：6400.49万 | | | 总股本：1.49亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 28,000,000 | 28,000,000 | 8,667,574.64 | 2,000,000 |
| 营业总成本 | 95,292,699 | 45,718,695.9 | 216,068,880.01 | 170,147,424.42 |
| 其他经营收益 | | | | |
| 营业利润 | -61,093,748.4 | -15,090,754.46 | -129,475,081.56 | -155,157,965.24 |
| 利润总额 | -61,059,407.4 | -15,090,754.46 | -128,834,243.41 | -154,767,127.09 |
| 净利润 | -61,059,407.4 | -15,090,754.46 | -128,834,243.41 | -154,767,127.09 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | -61,059,407.4 | -15,090,754.46 | -128,834,243.41 | -154,767,127.09 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 663,299,395.2 | 686,395,842.41 | 704,843,016.39 | 691,066,446.18 |
| 非流动资产: | | | | |
| 非流动资产合计 | 62,426,869.67 | 86,170,358.72 | 86,390,701.51 | 70,702,972.96 |
| 资产总计 | 725,726,264.87 | 772,566,201.13 | 791,233,717.9 | 761,769,419.14 |
| 流动负债: | | | | |
| 流动负债合计 | 101,856,058.64 | 99,598,947.88 | 102,139,614.39 | 107,040,215.45 |
| 非流动负债: | | | | |
| 非流动负债合计 | 4,750,744.1 | 7,879,138.18 | 8,915,233.98 | 483,217.84 |
| 负债合计 | 106,606,802.74 | 107,478,086.06 | 111,054,848.37 | 107,523,433.29 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 619,119,462.13 | 665,088,115.07 | 680,178,869.53 | 654,245,985.85 |
| 股东权益合计 | 619,119,462.13 | 665,088,115.07 | 680,178,869.53 | 654,245,985.85 |
| 负债和股东权益合计 | 725,726,264.87 | 772,566,201.13 | 791,233,717.9 | 761,769,419.14 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 31,656,721.93 | 25,630,842.51 | 72,806,421.98 | 4,594,995.66 |
| 经营活动现金流出小计 | 98,247,383.56 | 46,010,800.07 | 230,635,590 | 177,004,961.21 |
| 经营活动产生的现金流量净额 | -66,590,661.63 | -20,379,957.56 | -157,829,168.02 | -172,409,965.55 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,147,212,703.21 | 301,409,136.1 | 3,182,519,444.23 | 2,577,141,184.02 |
| 投资活动现金流出小计 | 1,049,157,659 | 281,582,848 | 3,025,041,962.63 | 2,417,461,537.68 |
| 投资活动产生的现金流量净额 | 98,055,044.21 | 19,826,288.1 | 157,477,481.6 | 159,679,646.34 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | - | - |
| 筹资活动现金流出小计 | 1,827,801.38 | 1,089,418.05 | 4,793,439.43 | 3,679,812.08 |
| 筹资活动产生的现金流量净额 | -1,827,801.38 | -1,089,418.05 | -4,793,439.43 | -3,679,812.08 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | 29,636,581.2 | -1,643,087.51 | -5,145,125.85 | -16,410,131.29 |
| 期末现金及现金等价物余额 | 47,226,197.63 | 15,946,528.92 | 17,589,616.43 | 6,324,610.99 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 29,636,581.2 | - | -5,145,125.85 | - |